Analyst Price Target is $23.00
▲ +70.12% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for SI-BONE in the last 3 months. The average price target is $23.00, with a high forecast of $32.00 and a low forecast of $18.00. The average price target represents a 70.12% upside from the last price of $13.52.
Current Consensus is
Buy
The current consensus among 6 investment analysts is to buy stock in SI-BONE. This Buy consensus rating has held steady for over two years.
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Read More